This will be in addition to its own efforts to develop a vaccine. The company said it is investing Rs 250-Rs 275 crore on a new facility to manufacture vaccines that would be ready by April. The facility will have the capacity to manufacture 400 - 450 million doses of vaccines.Aurobindo Pharma says ready to manufacture COVID-19 vaccines for others
This will be in addition to its own efforts to develop a vaccine. The company said it is investing Rs 250-Rs 275 crore on a new facility to manufacture vaccines that would be ready by April. The facility will have the capacity to manufacture 400 - 450 million doses of vaccines.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment